Oxford study to trial cannabis-based medicine as treatment for psychosis

CBD is currently only prescribed for a small number of conditions such as rare, severe epilepsy
The Guardian (UK)
Thursday, February 16, 2023

cannabinoidsOxford scientists are to launch a major global trial to investigate whether cannabis-based medicine can treat people with psychosis or psychotic symptoms. Currently, cannabidiol (CBD) is only prescribed for a small number of conditions. “Cannabidiol is one of the most promising new treatments for people with psychosis,” said Oxford’s Prof Philip McGuire, who is leading the trial. “Many people with psychosis are open to trying cannabidiol and previous smaller-scale studies have indicated that it has beneficial effects.” (See also: Study reveals how CBD helps counter epileptic seizures)